Solasta Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

17 Mar 2025

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

Maxion Therapeutics develops antibody-based KnotBody drugs targeting ion channels and GPCRs, advancing new treatments for inflammatory, pain and cardiovascular diseases with improved selectivity.

Solasta Ventures

- Life Sciences
solasta-ventures.com
Update Information

More venture news

Mindgard
12 Aug 2026
Mindgard secures £22m Series A led by Album VC to test and defend AI systems against adversarial attack
Series ACybersecurity
Cytix
12 Aug 2026
Cytix raises a £5m Series A round led by Northern Gritstone to manage the security risk of AI-driven software change
Series ACybersecurity
LemonEdge
29 Jul 2026
LemonEdge announced £16m Series A round led by Blackstone Innovations Investments for a fund accounting platform built for private markets
Series AFintech

Solasta Ventures

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

More venture news

Mindgard secures £22m Series A led by Album VC to test and defend AI systems against adversarial attack

Cytix raises a £5m Series A round led by Northern Gritstone to manage the security risk of AI-driven software change

LemonEdge announced £16m Series A round led by Blackstone Innovations Investments for a fund accounting platform built for private markets